anidulafungin has been researched along with Disseminated Fungal Infection in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, W; Lan, C; Liu, Y; Qin, S; Qin, Z; Zhang, P; Zhang, Z | 1 |
| Candoni, A; Facchin, G; Fanin, R; Lazzarotto, D | 1 |
| Li, Y; Liu, D; Liu, X; Pan, Y | 1 |
| Denis, J; Herbrecht, R; Ledoux, MP; Toussaint, E | 1 |
2 review(s) available for anidulafungin and Disseminated Fungal Infection
| Article | Year |
|---|---|
Efficacy of anti-fungal agents for invasive fungal infection prophylaxis in liver transplant recipients: A network meta-analysis.
Topics: Anidulafungin; Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Fungal Infections; Itraconazole; Liver Transplantation; Mycoses; Network Meta-Analysis; Randomized Controlled Trials as Topic; Transplant Recipients | 2022 |
Pharmacokinetic/pharmacodynamics variability of echinocandins in critically ill patients: A systematic review and meta-analysis.
Topics: Anidulafungin; Antifungal Agents; Area Under Curve; Caspofungin; Critical Illness; Echinocandins; Humans; Invasive Fungal Infections; Micafungin | 2020 |
2 other study(ies) available for anidulafungin and Disseminated Fungal Infection
| Article | Year |
|---|---|
18F-FDG Positron Emission Tomography (PET) Scan as a Useful Tool to Assess Response to Antimycotic Therapy in Disseminated Invasive Mycosis in Acute Myeloid Leukemia.
Topics: Aged; Anidulafungin; Antifungal Agents; Drug Combinations; Humans; Immunocompromised Host; Invasive Fungal Infections; Kidney; Leukemia, Myeloid, Acute; Liver; Male; Mycoses; Nitriles; Positron-Emission Tomography; Pyridines; Spleen; Treatment Outcome; Triazoles | 2020 |
New pharmacological opportunities for the treatment of invasive mould diseases.
Topics: Amphotericin B; Anidulafungin; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Echinocandins; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2017 |